Abstract
The increasing amounts of evidence prove that sex hormones modulate different cells function, including mast cells and lymphocytes. Dehydroepiandrosterone (DHEA) and its sulphate ester (DHEA-S) are both the secretory products of adrenal glands and the most abundant hormones in the systemic circulation of humans, converted then into androgens and estrogens in the periphery. DHEA may affect production of Th1 and Th2- associated cytokines, suggesting their significance in diseases where imbalanced lymphocyte activity plays the essential role, also in atopic diseases. Reduced circulating concentration of these androgens has been demonstrated in patients with immune-inflammatory diseases, including atopic eczema/dermatitis syndrome and asthma. It is unknown however, whether such changes contribute in any way to etiopathogenesis of the disorders, or are merely their consequences. Chronic urticaria, not included in the atopic triad, is a mast cell-dependent disease characterised by activation of autoimmune and inflammatory processes responding to different factors. Alterations in the immune-neuro-endocrine milieu may contribute to the development of the disease. It has been demonstrated that DHEA-S concentration is significantly lower in the peripheral circulation of patients suffering from chronic urticaria, as compared with healthy subjects. On one hand, this reflects some changes in hormonal homeostasis in the course of urticarial processes, yet on the other, suggests some possible role for this hormone in pathophysiology of the disease. In this brief review we present the available data on DHEA-S involvement in events associated with atopic allergy as well as chronic urticaria.
Similar content being viewed by others
Abbreviations
- AEDS:
-
atopic eczema/dermatitis syndrome
- DHEA:
-
dehydroepiandrosterone
- DHEA-S:
-
dehydroepiandrosterone sulphate
- DHEA(-S):
-
dehydroepiandrosterone and dehydroepiandrosterone sulphate
References
Wilder, R. L. 1995. Neuroendocrine-immune system interactions and autoimmunity. Annu. Rev. Immunol. 13:307–338.
Hamano, N., N. Terada, K. Maesako, T. Numata, and A. Konno. 1998. Effect of sex hormones on eosinophilic inflammation in nasal mucosa. Allergy Asthma Proc. 19:263–269.
Lima, A. P., L. O. Lunardi, and A. A. Rosa e Silva. 2000. Effects of castration and testosterone replacement on peritoneal histamine concentration and lung histamine concentration in pubertal male rats. J. Endocrinol. 167:71–75.
Daynes, R. A., D. J. Dudley, and B. A. Araneo. 1990. Regulation of murine lymphokine production in vivo. II. Dehydroepiandrosterone is a natural enhancer of interleukin 2 synthesis by helper T cells. Eur. J. Immunol. 20:793–802.
Pawlikowski, M. 2005. Adrenal cortex—the next biological clock. Neuro. Endocrinol. Lett. 26:193–195.
Rook, G. A., R. Hernandez-Pando, and S. L. Lightman. 1994. Hormones, peripherally activated prohormones and regulation of the Th1/Th2 balance. Immunol. Today 15:301–303.
Kroboth, P. D., F. S. Salek, A. L. Pittenger, T. J. Fabian, and R. F. Frye. 1999. DHEA and DHEA-S: a review. J. Clin. Pharmacol. 39:327–348.
Burger, H. G., E. C. Dudley, J. Cui, L. Dennerstein, and J. L. Hopper. 2000. A prospective longitudinal study of serum testosterone, dehydroepiandrosterone sulphate and sex hormone binding globulin levels through the menopause transition. J. Clin. Endocrinol. Metab. 85:2832–2938.
Burger, H. G. 2002. Androgen production in women. Fertill. Steril. 77(Suppl 4):S3–S5.
Lucas, J. A., S. A. Ahmed, M. L. Casey, and P. C. MacDonald. 1985. Prevention of autoantibody formation and prolonged survival in New Zealand Black/New Zealand White F1 mice fed dehydroisoandrosterone. J. Clin. Invest. 75:2091–2093.
Dillon, J. S. 2005. Dehydroepiandrosterone, dehydroepiandrosterone sulfate and related steroids: their role in inflammatory, allergic and immunological disorders. Curr. Drug Targets Inflamm. Allergy 4:377–385.
Cutolo, M., B. Seriolo, B. Villaggio, C. Pizzorni, C. Craviotto, and A. Sulli. 2002. Androgens and estrogens modulate the immune and inflammatory responses in rheumatoid arthritis. Ann. N. Y. Acad. Sci. 966:131–142.
Du, C., M. W. Khalil, and S. Sriram. 2001. Administration of dehydroepiandrosterone suppresses experimental allergic encephalomyelitis in SJL/J mice. J. Immunol. 167:7094–7101.
Straub, R. H., A. Schuld, J. Mullington, M. Haack, J. Schölmerich, and T. Pollmacher. 2002. The endotoxin-induced increase of cytokines is followed by an increase of cortisol relative to dehydroepiandrosterone (DHEA) in healthy male subjects. J. Endocrinol. 175:467–474.
Romagnani, S. 2000. T-cell subsets (Th1 versus Th2). Ann. Allergy Asthma Immunol. 85:9–21.
Suzuki, T., N. Suzuki, R. A. Daynes, and E. G. Engleman. 1991. Dehydroepiandrosterone enhances IL2 production and cytotoxic effector function of human T cells. Clin. Immunol. Immunopathol. 61:202–211.
Tabata, N., H. Tagami, and T. Terui. 1997. Dehydroepiandrosterone may be one of the regulators of cytokine production in atopic dermatitis. Arch. Dermatol. Res. 289:410–414.
Sudo, N., X. N. Yu, and C. Kubo. 2001. Dehydroepiandrosterone attenuates the spontaneous elevation of serum IgE level in NC/Nga mice. Immunol. Letters 79:177–179.
Yu, C. K., B. C. Yang, H. Y. Lei, Y. C. Chen, Y. H. Liu, C. C. Chen, and C. W. Liu. 1999. Attenuation of house dust mite Dermatophagoides farinae-induced airway allergic responses in mice by dehydroepiandrosterone is correlated with down-regulation of Th2 response. Clin. Exp. Allergy 29:414–422.
Yu, C. K., Y. H. Liu, and C. L. Chen. 2002. Dehydroepiandrosterone attenuates allergic airway inflammation in Dermatophagoides farinae-sensitized mice. J. Microbiol. Immunol. Infect. 35:199–202.
Dashtaki, R., A. R. Whorton, T. M. Murphy, P. Chitano, W. Reed, and T. P. Kennedy. 1998. Dehydroepiandrosterone and analogs inhibit DNA binding of AP-1 and airway smooth muscle proliferation. J. Pharmacol. Exp. Ther. 285:876–883.
Powell, J. M., and G. Sonnenfeld. 2006. Sonnenfeld. The effects of dehydroepiandrosterone (DHEA) on in vitro spleen cell proliferation and cytokine production. J. Interferon Cytokine Res. 26:34–39.
Ebata, T., R. Itamuram, H. Aizawa, and M. Niimura. 1996. Serum sex hormone levels in adult patients with atopic dermatitis. J. Dermatol. 23:603–605.
Kasperska-Zajac, A., Z. Brzoza, and B. Rogala. 2007. Serum concentration of dehydroepiandrosterone sulfate and testosterone in female patients suffering from severe atopic/dermatitis syndrome (AEDS). J. Invest. Allergol. Clin. Immunnol. 17:160–163.
Dunn, P. J., C. B. Mahood, J. F. Speed, and D. R. Jury. 1984. Dehydroepiandrosterone sulphate concentrations in asthmatic patients: pilot study. N. Z. Med. J. 97:805–808.
Kos-Kudla, B., Z. Ostrowska, B. Marek, N. Ciesielska-Kopacz, M. Kudla, D. Kajdaniuk, L. Siemidska, and J. Strzelczyk. 2001. Circadian serum levels of dehydroepiandrosterone sulphate in postmenopausal asthmatic women before and after long-term hormone replacement. Endocr. Regul. 35:217–222.
Nogueira, J. M., L. P. Pinto, V. Loureiro, S. Prates, A. Gaspar, M. M. Almeida, and J. E. Pinto. 1998. Soluble CD30, dehydroepiandrosterone sulfate and dehydroepiandrosterone in atopic and non atopic children. Allerg Immunol. (Paris) 30:3–8.
Greaves, M. W. 1995. Chronic urticaria. N. Engl. J. Med. 332:1767–1772.
Confino-Cohen, R., A. Goldberg, D. Aharoni, L. Naiman, A. Buchs, M. Weiss, J. Weissgarten, and M. J. Rapoport. 2004. Low stimulated IL-4 secretion in PBMC from patients with chronic idiopathic urticaria. Cytokine 27:74–80.
Schwartz, K. E.. 2002. Autoimmunity, dehydroepiandrosterone (DHEA), and stress. J. Adolesc. Health 30S:37–43.
Bertinotti, L., I. Miniati, and M. M. Cerinic. 2002. Angioedema and systemic sclerosis. A review of the literature. Scand. J. Rheumatol. 31:178–180.
Kasperska-Zajac, A., Z. Brzoza, and B. Rogala. 2006. Serum concentration of dehydroepiandrosterone sulphate in female patients with chronic idiopathic urticaria. J Dermatol. Sci. 41:80–81.
Kasperska-Zajac, A., Z. Brzoza, and B. Rogala. 2006. Lower serum concentration of dehydyroepiandrone sulphate in patients with chronic idiopathic urticaria. Allergy 61:1489–1490.
Brzoza, Z., A. Kasperska-Zajac, and B. Rogala. 2007. Serum prolactin concentration and its relationship with dehydroepiandrosterone sulfate concentration in chronic urticaria patients with positive and negative response to autologous serum skin test. Allergy 62:566–567.
Kasperska-Zajac, A., Z. Brzoza, and B. Rogala. 2007. Plasma concentration of interleukin 6 (IL-6), and its relationship with circulating concentration of dehydroepiandrosterone sulfate (DHEA-S) in patients with chronic idiopathic urticaria. Cytokine 39:142–146.
Kasperska-Zajac, A., Z. Brzoza, and B. Rogala. 2007. Circulating concentration of dehydroepiandrosterone sulfate (DHEA-S) in women suffering from chronic idiopathic urticaria in relation to their pre- or post-menopausal status. Maturities 58:211–215.
Kasperska-Zajac, A., Z. Brzoza, K. Badura-Brzoza, J. Matysiakiewicz, R. T. Hese, and B. Rogala. 2007. Does the dehydroepiandrosterone sulphate decline in chronic urticaria result from psychological distress. Allergy 62(s83):1640 poster.
Murakami, K., T. Nakagawa, G. Yamashiro, K. Araki, and K. Akasofu. 1993. Adrenal steroids in serum during danazol therapy, taking into account cross-reactions between danazol metabolites and serum androgens. Endocr. J. 40:659–664.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Kasperska-Zajac, A., Brzoza, Z. & Rogala, B. Dehydroepiandrosterone and Dehydroepiandrosterone Sulphate in Atopic Allergy and Chronic Urticaria. Inflammation 31, 141–145 (2008). https://doi.org/10.1007/s10753-008-9059-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10753-008-9059-1